Research Results

Our study demonstrates significant improvements in PTSD symptoms across both treatment modalities, with some notable differences in effectiveness and participant engagement.

Symptom Reduction

53%

Average reduction in PTSD symptoms for ITR group

Participants

240

Total study participants across both groups

Duration

12

Weeks of treatment per participant

Completion Rate

85%

Treatment completion rate for ITR group

PTSD Symptom Reduction Over Time

Average PCL-5 scores across treatment groups

Treatment Completion Rates

Percentage of participants by completion status

Key Findings

The study revealed several important findings about the comparative effectiveness of ITR and TF-CBT in treating PTSD:

  • ITR showed a slightly higher rate of symptom reduction (53%) compared to TF-CBT (47%) over the 12-week treatment period.
  • Both treatments demonstrated good completion rates, with ITR showing marginally better retention (85% vs 82%).
  • Participants in the ITR group reported faster initial improvement in symptoms during the first 6 weeks of treatment.
  • Long-term follow-up (6 months post-treatment) showed sustained improvements in both groups.

Clinical Implications

These results suggest that while both ITR and TF-CBT are effective treatments for PTSD, ITR may offer some advantages in terms of early symptom reduction and treatment retention. However, individual patient factors should still guide treatment selection.